SOFINNOVA INVESTMENTS, INC. 13F Portfolio
SOFINNOVA INVESTMENTS, INC. runs SOFINNOVA INVESTMENTS, INC. and currently holds 57 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $1.93B. Their top holdings are NTRA, VERA, GMAB, JAZZ, RAPP. The top five represent 42.4% of reported portfolio weight. SOFINNOVA INVESTMENTS, INC. ranks #252 out of 1000 investors tracked by Alpha Score. In the most recent quarter, SOFINNOVA INVESTMENTS, INC. initiated 9 new positions. They added to 8 existing positions. They trimmed 17 positions. Their current best-performing preview position is DFTX with returns of +148.89%.
Portfolio Value
$1.93B
Alpha Score
81.7
#252 of 1000
Holdings
57
SOFINNOVA INVESTMENTS, INC. Current 13F Holdings
Reported holdings from SOFINNOVA INVESTMENTS, INC.'s latest SEC 13F filing, ranked by portfolio weight.
57 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 NTRA Natera Inc | 21.76% | $9.35 | $400.71 | +4,185.67% | Held |
 VERA Vera Therapeutics Inc | 6.20% | $13.59 | $29.88 | +119.87% | Held |
 GMAB Genmab A/S | 5.74% | $27.35 | $37.07 | +35.54% | Added +437.74% |
 JAZZ Jazz Pharmaceuticals PLC | 4.55% | $136.54 | $218.42 | +59.97% | Trimmed -38.94% |
 RAPP Rapport Therapeutics Inc | 4.10% | $25.33 | $30.65 | +21.00% | Held |
SP SPTX Seaport Therapeutics Inc | 4.00% | $21.72 | $18.15 | -16.44% | New Buy |
 AVBP Arrivent BioPharma Inc | 3.05% | $18.31 | $16.73 | -8.63% | Held |
 RARE Ultragenyx Pharmaceutical In | 2.96% | $21.00 | $15.48 | -26.29% | Trimmed -45.40% |
 BIOA BioAge Labs Inc | 2.91% | $20.80 | $6.34 | -69.52% | Held |
 BMY Bristol-Myers Squibb Co | 2.61% | $55.55 | $59.11 | +6.41% | Trimmed -55.90% |
Showing 1-10 of 57